Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical Lymphoma, Myeloma & Leukemia|February 14, 2018
Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual DiseaseThomas A Ollila, Adam J Olszewski, James N Butera, et al.
Rhode Island Medical Journal (2013)|February 27, 2023
Testicular Relapse of Primary Diffuse Large B-cell Lymphoma of the Central Nervous System - a Rare OccurrenceThomas A Ollila, Thomas P Kishkovich, Adam J Olszewski, et al.
Rhode Island Medical Journal (2013)|October 2, 2020
Enforcing the "4T": An In-Line Calculator for HIT Antibody Ordering in the Electronic Medical RecordAdam S Zayac, Ross W Hilliard, Adam J Olszewski, et al.
Haematologica|November 27, 2025
Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphomaAdam J Olszewski, Thomas A Ollila, Dai Chihara, et al.
Cancer|July 11, 2022
Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignanciesThomas A Ollila, Rebecca H Masel, John L Reagan, et al.
Blood Advances|September 22, 2021
Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphomaAdam J Olszewski, Anna D Chorzalska, Max Petersen, et al.
Blood Cancer Journal|June 21, 2025
Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma-Results from a multicenter cohort studyFrederique St-Pierre, Subodh Bhatta, Peter G Doukas, et al.
Blood|April 21, 2026
Mosunetuzumab plus polatuzumab vedotin in relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 studyLihua E Budde, Manali Kamdar, Sarit E Assouline, et al.
Blood Advances|March 26, 2024
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapyReem Karmali, Rushad Machhi, Narendranath Epperla, et al.
Blood Advances|February 26, 2026
Real-World Outcomes and Toxicities of CAR-T in Relapsed/Refractory Follicular Lymphoma: A Multicenter Cohort StudyJohn Sharp, Paolo Strati, Subodh Bhatta, et al.
Pageof 3